IP Library › Granted Patent US 10,385,312
Granted Patent B2
US 10,385,312 · App. 15/209,776 · Granted Aug 20, 2019

Media for culturing stem cells

Inventors: Michal Amit (Misgav, IL); Joseph Itskovitz-Eldor (Haifa, IL)
Assignee: Technion Research & Development Foundation Limited
C12N5/0606C12N5/0037C12N5/0043C12N5/0056C12N5/0602C12N5/0603C12N2500/90C12N2500/98C12N2501/115C12N2501/15C12N2501/23C12N2501/2306C12N2506/02C12N2533/52
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,385,312
App. No.
15/209,776
Granted
Aug 20, 2019
Kind
B2
Abstract

Well-defined, xeno-free culture media which comprise a TGF-beta isoform or the chimera formed between IL6 and the soluble IL6 receptor (IL6RIL6), which are capable of maintaining stem cells, and particularly, human embryonic stem cells, in an undifferentiated state are provided. Also provided are cell cultures comprising the culture media and the stem cells and methods of expanding and deriving embryonic stem cells in such well-defined, xeno-free culture media. In addition, the present invention provides methods of differentiating ESCs or EBs formed therefrom for the generation of lineage specific cells.

Claims (15)

1. A method of culturing primate pluripotent stem cells in a pluripotent and undifferentiated state, the method comprising culturing the primate pluripotent stem cells in a suspension culture which comprises a culture medium, said culture medium comprising basic fibroblast growth factor (bFGF) and at least one factor selected from the group consisting of transforming growth factor beta-3 (TGFβ3) isoform, transforming growth factor beta-1 (TGFβ1) isoform, and IL6RIL6 chimera, wherein the primate pluripotent stem cells are expanded for at least 5 passages in said suspension culture without adherence to an external substrate, wherein the primate pluripotent stem cells are maintained in said suspension culture in a pluripotent and undifferentiated state, wherein the pluripotent stem cells express OCT4, and are capable of forming teratomas containing cells of the mesoderm, ectoderm and endoderm embryonic germ layers.

2. The method of claim 1 , wherein said culturing is in a bioreactor.

3. The method of claim 1 , wherein the primate pluripotent stem cells comprise primate embryonic stem cells.

4. The method of claim 1 , wherein said culture medium is devoid of serum.

5. The method of claim 1 , wherein said culture medium is devoid of serum replacement.

6. The method of claim 1 , wherein said culture medium is animal contaminant-free.

7. The method of claim 1 , wherein said suspension culture is feeder cell layer-free.

8. The method of claim 1 , wherein said culture medium is protein carrier-free.

9. The method of claim 1 , wherein said IL6RIL6 chimera comprises amino acids 112-355 of SEQ ID NO: 32.

10. The method of claim 1 , wherein said IL6RIL6 chimera is provided at a concentration of at least 25 ng/ml.

11. The method of claim 1 , wherein said bFGF is provided at a concentration of at least 2 ng/ml.

12. The method of claim 1 , wherein said TGFβ3 is at a concentration of at least 0.5 ng/ml.

13. The method of claim 1 , wherein said TGFβ1 is at a concentration of at least 0.06 ng/ml.

14. The method of claim 1 , wherein said primate pluripotent stem cells are human pluripotent stem cells.

15. The method of claim 1 , wherein said primate pluripotent stem cells are monkey pluripotent stem cells.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 10, 2016
From: AMIT, MICHAL; ITSKOVITZ-ELDOR, JOSEPH
To: TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED
Reel/Frame 039392/0039 →
Continuity (5)
Continuation 13909128 · Jun 4, 2013
Division 11991077
Provisional Application 60834795 · Aug 2, 2006
Provisional Application 60711668 · Aug 29, 2005
Related Publication 20160319241A1 · Nov 3, 2016
Cited By (2)
US 12,391,918 US 12,415,985